HuGE Literature Finder
Records
1
-
3
FOLFIRI® and bevacizumab in first-line treatment for colorectal cancer patients: safety, efficacy and genetic polymorphisms. BMC research notes 2014 7 (1): 260. Bécouarn Yves, Cany Laurent, Pulido Marina, Beyssac Richard, Texereau Patrick, Le Morvan Valérie, Béchade Dominique, Brunet René, Aitouferoukh Sofiane, Lalet Caroline, Mathoulin-Pélissier Simone, Fonck Marianne, Robert Jacqu |
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors. Investigational new drugs 2012 Nov . Infante JR, Novello S, Ma WW, Dy GK, Bendell JC, Huff A, Wang Q, Suttle AB, Allen R, Xu CF, Ottesen LH, Burris HA, Adjei AA |
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC cancer 2012 12 (1): 107. Rutkowski Piotr, Bylina El?bieta, Klimczak Anna, Switaj Tomasz, Falkowski S?awomir, Kroc Jacek, Lugowska Iwona, Brzeskwiniewicz Magdalena, Melerowicz Wojciech, Osuch Czes?aw, Mierzejewska Ewa, Wasielewski Kacper, Wo?niak Agnieszka, Grzesiakowska Urszula, Nowecki Zbigniew I, Siedlecki Janusz A, Limon Janu |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: